HIF1A and cervical carcinoma: Interestingly, HIF1α represents a key orchestrator of radioresistance [52] and paclitaxel resistance of cervical cancer [53]: even if these therapeutic approaches have various mechanisms of action, they all lead to an increase in ROS production.